U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C39H32ClF10N7O5S2
Molecular Weight 968.282
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LENACAPAVIR

SMILES

[H][C@]12C[C@@]1([H])C(F)(F)C3=C2C(=NN3CC(=O)N[C@@H](CC4=CC(F)=CC(F)=C4)C5=NC(=CC=C5C6=CC=C(Cl)C7=C6N(CC(F)(F)F)N=C7NS(C)(=O)=O)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F

InChI

InChIKey=BRYXUCLEHAUSDY-WEWMWRJBSA-N
InChI=1S/C39H32ClF10N7O5S2/c1-36(2,63(3,59)60)10-9-21-5-6-22(23-7-8-26(40)30-32(23)57(17-37(43,44)45)54-35(30)55-64(4,61)62)31(51-21)27(13-18-11-19(41)14-20(42)12-18)52-28(58)16-56-34-29(33(53-56)39(48,49)50)24-15-25(24)38(34,46)47/h5-8,11-12,14,24-25,27H,13,15-17H2,1-4H3,(H,52,58)(H,54,55)/t24-,25+,27-/m0/s1

HIDE SMILES / InChI

Molecular Formula C39H32ClF10N7O5S2
Molecular Weight 968.282
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 14:10:10 GMT 2023
Edited
by admin
on Sat Dec 16 14:10:10 GMT 2023
Record UNII
A9A0O6FB4H
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LENACAPAVIR
USAN   INN  
Official Name English
N-((1S)-1-(3-(4-CHLORO-3-(METHANESULFONAMIDO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-(METHANESULFONYL)-3-METHYLBUT-1-YN-1-YL)PYRIDIN-2-YL)-2-(3,5- DIFLUOROPHENYL)ETHYL)-2-((3BS,4AR)-5,5-DIFLUORO-3-(TRIFLUOROMETHYL)-3B,4,4A,5-TETRAHYDRO-1H-CYCLOPR
Systematic Name English
1H-CYCLOPROPA(3,4)CYCLOPENTA(1,2-C)PYRAZOLE, N-((1S)-1-(3-(4-CHLORO-3-((METHYLSULFONYL)AMINO)-1-(2,2,2-TRIFLUOROETHYL)-1H-INDAZOL-7-YL)-6-(3-METHYL-3-(METHYLSULFONYL)-1-BUTYN-1-YL)-2-PYRIDINYL)-2-(3,5-DIFLUOROPHENYL)ETHYL)-5,5-DIFLUORO-3B,4,4A,5-TETRAHYD
Systematic Name English
lenacapavir [INN]
Common Name English
LENACAPAVIR [USAN]
Common Name English
Lenacapavir [WHO-DD]
Common Name English
GS6207
Code English
GS-HIV
Common Name English
GS-6207
Code English
GS-CA-2
Code English
GS-714207
Code English
GS-CA2
Code English
Code System Code Type Description
INN
11108
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
PUBCHEM
133082658
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
USAN
JK-52
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
DRUG BANK
DB15673
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
NCI_THESAURUS
C174616
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
DAILYMED
A9A0O6FB4H
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
FDA UNII
A9A0O6FB4H
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
CAS
2189684-44-2
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
SMS_ID
300000007900
Created by admin on Sat Dec 16 14:10:11 GMT 2023 , Edited by admin on Sat Dec 16 14:10:11 GMT 2023
PRIMARY
Related Record Type Details
BINDER->LIGAND
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
METABOLIC ENZYME -> SUBSTRATE
EXCRETED UNCHANGED
FECAL
METABOLIC ENZYME -> SUBSTRATE
MINOR
METABOLIC ENZYME -> INHIBITOR
Moderate inhibitor
MINOR
TARGET->INHIBITOR OF AGGREGATION
Long acting drug
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC Route of administration
PHARMACOKINETIC
Volume of Distribution PHARMACOKINETIC Route of administration
PHARMACOKINETIC